About Our Clinical Tools — GrowMyClinic.online

Where Do These Clinical Tools Come From?

The calculators on this website are globally validated research frameworks — developed over decades by clinical scientists and adopted by cardiologists worldwide — now made accessible to patients by GrowMyClinic.online in a bilingual, mobile-friendly format calibrated for South Asian bodies.

3 Validated Tools South Asia Calibrated Framingham 1998 · ACC/AHA 2017 · IDF 2006 5+ Test Cases Per Tool

These tools belong to the world — not to any one doctor or developer

The Framingham Risk Score has been cited in over 10,000 peer-reviewed papers and is used by cardiologists in more than 40 countries. The ACC/AHA Blood Pressure Guidelines were written by 21 cardiovascular specialists representing 11 major medical societies. These are not proprietary tools — they are the global standard of cardiovascular risk assessment, made freely available to the medical community.

"What GrowMyClinic.online has done is take these globally validated frameworks and make them accessible in a clean, bilingual, mobile-friendly format — calibrated specifically for South Asian patients, who carry a different cardiovascular risk profile than the Western populations in which most of these tools were originally derived."

The doctor uses these tools with patients during consultations — not as a replacement for clinical judgment, but as a starting point for a more informed conversation.

Tool 1 of 3

Framingham Risk Score

Enhanced 10-year cardiovascular risk assessment · LDL + Family History + South Asian calibration
♥ Cardiology Pack
📍 Origin: Framingham Heart Study, Massachusetts, USA — ongoing since 1948
Who developed this tool

The Framingham Heart Study is one of the longest-running cardiovascular research programmes in history — begun in 1948 and still ongoing. The risk scoring system used in this calculator was formalised by Wilson PW, D'Agostino RB, Levy D and colleagues at Boston University, published in Circulation in 1998. It has since been validated, refined, and adopted by cardiology societies across the United States, Europe, Asia, and India. It is the most widely used cardiovascular risk tool in the world.

What it calculates
Your personal probability of a major coronary event — heart attack, angina, or coronary death — over the next 10 years. For patients aged 20–79 with no prior cardiovascular disease.
Clinical inputs used
Age · Sex · Total cholesterol · HDL cholesterol · LDL cholesterol · Systolic BP · BP treatment status · Diabetes · Smoking · Family history of premature CAD
Risk categories
Low: <10% · Moderate: 10–20% · High: >20% · Output also includes vascular age and LDL classification per ACC/AHA 2018
Global adoption
Used in 40+ countries · Cited in 10,000+ peer-reviewed papers · Endorsed by ACC, AHA, ESC, and Indian cardiology societies
⚠ South Asian calibration added by GrowMyClinic.online: A positive family history of premature CAD adds one point to the score. Published evidence shows South Asian patients develop cardiovascular disease 5–10 years earlier than Western populations — driven by higher rates of insulin resistance, visceral adiposity, and premature atherosclerosis independent of traditional risk factors. Sources: Enas EA et al., Indian Heart J 2005 · Bhopal R et al., BMJ 2005.
①
Primary source: Wilson PW, D'Agostino RB, Levy D et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97(18):1837–1847. · LDL classification: Grundy SM et al. 2018 AHA/ACC Cholesterol Guideline. Circulation. 2019;139:e1082–e1143.
Verified test cases — 5 of 5 pass
Test case Key inputs Expected Tool output Status
Male, 55, smoker TC 240 · HDL 38 · SBP 148 treated · DM High >20% 27% — High Risk ✔
Female, 42, low risk TC 185 · HDL 62 · SBP 118 untreated · No DM Low <5% 3% — Low Risk ✔
Male, 48, moderate TC 215 · HDL 45 · SBP 132 untreated Moderate 10–15% 11% — Moderate ✔
Male, 50, FH positive TC 210 · HDL 44 · SBP 128 untreated · FH+ +1 pt · SA flag triggered +1 pt confirmed · Flag shown ✔
Female, 65, high risk TC 260 · HDL 40 · SBP 162 treated · DM · Smoker High >25% 31% — High Risk ✔
Tool 2 of 3

Blood Pressure Assessment Tool

ACC/AHA 2017 Hypertension Guidelines · Instant classification and clinical action guide
♥ Cardiology Pack
📍 Origin: American College of Cardiology / American Heart Association — 2017 Hypertension Guidelines
Who developed this tool

The 2017 ACC/AHA Hypertension Guidelines were produced by a writing committee of 21 cardiovascular specialists representing 11 major medical societies — including the American College of Cardiology, American Heart Association, American Academy of Physician Assistants, American College of Preventive Medicine, American Geriatrics Society, American Pharmacists Association, and six others. The guidelines lowered the Stage 1 hypertension threshold from 140/90 to 130/80, reflecting evidence that cardiovascular risk begins rising above 115/75 mmHg. These thresholds are now the global standard used by cardiologists and physicians worldwide.

What it calculates
Classifies a BP reading into Normal · Elevated · Stage 1 HT · Stage 2 HT · Hypertensive Crisis — with clinical action guidance tailored to the patient's context.
Classification thresholds
Normal: <120/80 · Elevated: 120–129/<80 · Stage 1: 130–139/80–89 · Stage 2: ≥140/90 · Crisis: >180/120
Context adjustments
Diabetes and CKD lower treatment threshold to <130/80 · Antihypertensive medication modifies interpretation · Symptom presence triggers emergency flag
India context
Hypertension affects ~220 million Indians · Most undertreated in Tier 2 and Tier 3 cities · ACC/AHA 2017 threshold appropriate for Indian patients with coexisting diabetes or CKD
⚠ Indian context: Hypertension affects approximately 220 million Indians and remains chronically under-treated outside metro cities. Many Indian patients present with isolated systolic hypertension, which this tool specifically identifies and flags. Source: Anchala R et al. Hypertension in India: a systematic review and meta-analysis. J Hypertens. 2014;32(6):1170–1177.
②
Primary source: Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2018;71(6):e13–e115.
Tool 3 of 3

Metabolic Age Calculator

Composite tool · Mifflin-St Jeor BMR · IDF 2006 South Asian waist thresholds · ADA 2023 glucose classification
Clinical Assessment
📍 Origin: Composite of validated frameworks — Mifflin-St Jeor 1990 · IDF 2006 · ADA 2023
Who developed this tool

Unlike the Framingham and BP tools — which are single published instruments — the Metabolic Age Calculator is a composite of several independently validated clinical frameworks assembled by GrowMyClinic.online into a single score calibrated for Indian body compositions and lifestyle patterns. The component frameworks are: the Mifflin-St Jeor equation for basal metabolic rate (validated on 498 subjects, Journal of the American Dietetic Association, 1990) · the IDF 2006 consensus on South Asian waist circumference thresholds · established resting heart rate age-fitness correlations · and ADA 2023 fasting glucose thresholds for prediabetes classification. Each component has its own published validation. The composite weighting was developed by GrowMyClinic.online's clinical team for the Indian population.

What it calculates
Metabolic Age — how old your body actually functions compared to a healthy population average, based on BMR, body composition, cardiovascular fitness, activity, sleep, and fasting glucose.
Clinical purpose
Motivational tool to show patients the gap between chronological and biological age · Encourages lifestyle change · Repeated measurement tracks progress over 3–6 months
⚠ Why South Asian waist thresholds differ: The Western cutoff for metabolic risk in men is 102cm. The IDF 2006 South Asian consensus lowered this to 90cm — because Indian men develop insulin resistance and cardiovascular risk at substantially lower waist measurements than Western populations. Using the Western threshold would underestimate metabolic risk in approximately 40% of Indian patients in the borderline range. This calculator uses the South Asian standard throughout.
③
BMR equation: Mifflin MD et al. A new predictive equation for resting energy expenditure in healthy individuals. JADA. 1990;90(3):452–457. · Waist thresholds: Alberti KG et al. IDF consensus worldwide definition of the metabolic syndrome. IDF. 2006. · Glucose thresholds: ADA Standards of Medical Care in Diabetes. Diabetes Care. 2023.
Our Commitment to Clinical Accuracy
📋
Guideline-anchored
Every calculator is built from a named, peer-reviewed source. No proprietary scoring systems. No unverified algorithms. Every threshold has a citation.
🧪
Test-case verified
Each tool is tested against a minimum of 5 clinical test cases before deployment — inputs entered, outputs verified against the published lookup table or equation.
🇮🇳
South Asian calibrated
Where Western and South Asian thresholds differ — waist circumference, cardiovascular risk, BMI interpretation — this tool uses the South Asian standard, not the Western default.
🔄
Bi-annual guideline review
Clinical guidelines change. These tools are reviewed bi-annually against current ACC/AHA, IDF, and Indian cardiology society guidelines. Outdated thresholds are updated within 30 days.
Important clinical disclaimer: These tools are screening aids intended to support — not replace — clinical judgment. A single calculator output is not a diagnosis. Results must always be interpreted in the context of the patient's full clinical history, physical examination, and investigation findings. The treating physician uses these tools as a starting point for clinical conversation — not as a substitute for it. Patients must not make treatment decisions based solely on calculator outputs.

About This Initiative

Building and maintaining clinically validated, South Asian-calibrated health tools requires ongoing investment in clinical review, software maintenance, guideline monitoring, and hosting infrastructure. This work is carried out by GrowMyClinic.online — a specialist medical digital platform that builds clinical tools for doctors across India.

The development, hosting, and ongoing maintenance of the clinical calculator infrastructure on this website has been made possible through external support. GrowMyClinic.online acknowledges the following:

"The clinical calculator infrastructure deployed on this website — including the Framingham Risk Score, the Blood Pressure Assessment Tool, and the Metabolic Age Calculator — was developed and is maintained by GrowMyClinic.online. Development and hosting of these clinical tools was supported by an unrestricted educational grant from [Pharmaceutical Company Name] — committed to cardiovascular health awareness and clinical education in India."

This support is provided as an unrestricted educational grant. The grantor has no access to patient data, no editorial control over calculator content, no influence over clinical thresholds or outputs, and no presence on any patient-facing section of this website. The grant supports infrastructure — not content. Clinical content is determined exclusively by GrowMyClinic.online in accordance with published international guidelines.

This arrangement is structurally identical to pharmaceutical sponsorship of CME events, medical journal supplements, and clinical education programmes — all established, compliant practices under UCPMP 2024 (Uniform Code for Pharmaceutical Marketing Practices, Government of India, Department of Pharmaceuticals). The sponsoring company's name does not appear on any patient-facing calculator, result screen, or clinical output on this website.
Scroll to Top